Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Idebenone in Leber's Hereditary Optic Neuropathy
NCT00747487Phase 2Completed
- Sponsor
- Santhera Pharmaceuticals
- Start
- Nov 2007
- Primary completion
- Feb 2010
- Modality
- Small Molecules
- Countries
- 3
01
Overview
A Phase 2 trial of idebenone in Leber hereditary optic neuropathy (LHON), sponsored by Santhera Pharmaceuticals. Started Nov 2007; status: completed.
02
Drugs
idebenone
03
Conditions
Leber hereditary optic neuropathy (LHON)
Beyond the preview
Go deeper on NCT00747487.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00747487.